These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37410230)

  • 1. Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview.
    Seillier L; Peifer M
    Methods Mol Biol; 2023; 2684():113-132. PubMed ID: 37410230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
    Silva TA; Azevedo H
    J Proteomics; 2020 Oct; 229():103951. PubMed ID: 32860965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.
    Zhao YG; Shi BY; Qian YY; Bai HW; Xiao L; He XY
    Tumori; 2014; 100(6):e273-81. PubMed ID: 25688510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Implications of Immunohistochemical Biomarkers in Non-muscle-invasive Blad Cancer and Muscle-invasive Bladder Cancer.
    Boegemann M; Krabbe LM
    Mini Rev Med Chem; 2020; 20(12):1133-1152. PubMed ID: 27173513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational Landscape of Bladder Cancer in Mexican Patients:
    Pérez-Montiel MD; Cerrato-Izaguirre D; Sánchez-Pérez Y; Diaz-Chavez J; Cortés-González CC; Rubio JA; Jiménez-Ríos MA; Herrera LA; Scavuzzo A; Meneses-García A; Hernández-Martínez R; Vaca-Paniagua F; Ramírez A; Orozco A; Cantú-de-León D; Prada D
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of bladder cancer genomics: What have we learned and how can we use it?
    Audenet F; Attalla K; Sfakianos JP
    Urol Oncol; 2018 Jul; 36(7):313-320. PubMed ID: 29573965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
    Yang D; Ma Y; Zhao P; Ma J; He C
    Biomed Pharmacother; 2019 Dec; 120():109433. PubMed ID: 31568988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression.
    Piao XM; You C; Byun YJ; Kang HW; Noh J; Lee J; Lee HY; Kim K; Kim WT; Yun SJ; Lee SC; Kang K; Kim YJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
    Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
    Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
    Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
    BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
    Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic characterization of high-risk non-muscle invasive bladder cancer.
    Meeks JJ; Carneiro BA; Pai SG; Oberlin DT; Rademaker A; Fedorchak K; Balasubramanian S; Elvin J; Beaubier N; Giles FJ
    Oncotarget; 2016 Nov; 7(46):75176-75184. PubMed ID: 27750214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study.
    Kim BW; Ha YS; Lee JN; Kim HT; Kim TH; Lee JK; Byun SS; Choi YD; Kang HW; Yun SJ; Kim WJ; Kwon YS; Kwon TG
    Urol J; 2015 Sep; 12(4):2233-9. PubMed ID: 26341764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives.
    Ohishi T; Koga F; Migita T
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer.
    Lee EK; Ye Y; Kamat AM; Wu X
    Cancer; 2013 May; 119(9):1643-51. PubMed ID: 23529717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio.
    Kaynar M; Yıldırım ME; Badem H; Caviş M; Tekinarslan E; Istanbulluoğlu MO; Karataş ÖF; Çimentepe E
    Tumour Biol; 2014 Jul; 35(7):6601-5. PubMed ID: 24696263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
    Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
    Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
    Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
    Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.